Stock Radar: Strides Pharma stock hits fresh 52-week high in July; will the rally continue in August?

Strides Pharma Science Limited stock shows positive momentum. It broke a one-month consolidation in July 2025. Experts suggest a buy for a target of Rupees 975 to Rupees 1030. This is expected over the next one to two months. The stock recently reclaimed its 200-DMA. Analysts advise a stop loss at Rupees 895. The stock exhibits strength with bullish indicators.